VERISTRA
LIVE

Serial Number

99331922

Owner

Health Data Works, Inc.

Attorney

Fernando A. Dutra

Filing Date

Aug 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

VERISTRA Trademark

Serial Number: 99331922

VERISTRA is a trademark filed by Health Data Works, Inc. on August 11, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Health Data Works, Inc. (3 trademarks)

7643 Gate Parkway
Jacksonville, FL 32256

Entity Type: 03

Trademark Details

Filing Date

August 11, 2025

Registration Date

Not Registered

Goods & Services

Downloadable computer software and downloadable mobile applications for dialysis tracking and management; Downloadable computer software and downloadable mobile applications for enabling patients and physicians to communicate with each other outside the examination room for dialysis treatment and management; Downloadable software, namely, a mobile application for use by patients and patient caregivers and support partners to monitor, track, and report symptoms, symptom relief, quality of life, and other dialysis related information; Downloadable Software as a Medical Device (SaMD) for dialysis tracking and management; Recorded Software as a Medical Device (SaMD) for dialysis tracking and management; Recorded computer networking software; Recorded mobile operating system software; Downloadable medical software for patient monitoring; Recorded medical software for patient monitoring; Downloadable medical software for monitoring and managing dialysis access sites; Downloadable artificial intelligence software for predictive analytics; Downloadable machine learning software for data analysis and risk assessment; Downloadable computer software featuring artificial intelligence for predicting complications and treatment outcomes; Downloadable Mobile applications for patient monitoring and data collection; Downloadable software for processing data using large language models (LLMs) and artificial intelligence algorithms.

Remote patient monitoring services; Medical monitoring services for dialysis patients; Medical diagnostic services, namely, monitoring and analysis of access sites in dialysis patients; Medical consultation services in the field of dialysis access management; Providing medical information and alerts regarding patient access complications; Medical services, namely, predictive monitoring and early intervention for dialysis access failures.

Software as a service (SAAS) services featuring software for a dialysis access management platform; Software as a service (SAAS) services featuring software for enabling users to query dialysis treatment data for users to download and populate the user information systems, namely, electronic medical records systems; Providing temporary use of online non-downloadable cloud-based middleware for providing an interface between dialysis treatment data collection and the interface to the user medical information systems; Software as a service (SAAS) services featuring online software for use by physicians and other healthcare providers and staff to monitor and track dialysis management; Software as a service (SAAS) services featuring online software to provide data, data analysis and decision-support for care of patients with dialysis clinic staff and other healthcare providers and personnel, caregivers, and family members; Software as a service (SAAS) services featuring software for enabling patients and physicians to communicate with each other outside the examination room for dialysis treatment and management; Software as a service (SaaS) featuring artificial intelligence and machine learning software algorithms for analysis and predictive modeling; Platform as a service (PaaS) featuring monitoring and diagnostic software; computer services, namely, artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for providing artificial intelligence-powered predictive analytics for risk assessment and intervention recommendations; Software as a service (SaaS) featuring large language model (LLM) processing software for insights and clinical decision support; Cloud computing services featuring artificial intelligence software for processing and analyzing data to predict patient outcomes and access management complications; Scientific research services using artificial intelligence and predictive analytics; Computer software design and development in the field of artificial intelligence.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 26, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 25, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 26, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 26, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 29, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 29, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 29, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 11, 2025 MAFR
NEW APPLICATION ENTERED
Aug 11, 2025 NWAP